ABCC2 and intrahepatic cholestasis: In addition, mutations in the Notch signaling pathway frequently cause infant cholestasis in Alagille syndrome1 and mutations/polymorphisms inMDR3, multidrug resistance-associated protein 2 (MRP2), andFXR have been associated with intrahepatic cholestasis of pregnancy or drug-induced liver injury1.